Treatment of eruptive lichen planus with oral acyclovir | Journal of Pakistan Association of Dermatologists 2020

Author(s)

Aliya Akhtar Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Nighat Fatima Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Farah Sattar Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Shazia Zubair Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Sumara Rashid Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Mehwish Saeed Department of Dermatology, Nishtar Medical University, Multan, Pakistan

Abstract

Objective To measure the efficacy of oral acyclovir for treatment of eruptive lichen planus. Methods This quasi experimental study was done in outpatient department of Dermatology, Nishtar Medical University, Multan, from 01-05-2018 to 31-10-2018. Total thirty patients of eruptive lichen planus of either sex and age ranging from 18 - 65 years were included in this study. They were given oral acyclovir 400 mg three times a day for six weeks. Patients were followed up at three and six weeks and then up to three months to find out the efficacy of treatment. Results A total of 30 patients were enrolled in the study with mean age of 37.76%±13.92. Males were 46.66% and females were 53.33%. 23 out of total 30 (76.7%) patients showed effective response to oral acyclovir. Conclusion Oral Acyclovir is an effective and innovative treatment for eruptive lichen planus.

Publication Details

Page(s) 53-57

DOI DOI not available

Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 30, Issue: 1, Year: 2020

Keywords

Eruptive lichen planus eLP acyclovir Acv diabetes mellitus DM upper respiratory tract infection URTI hepatitis B virus HBV hepatitis C virus HCV

References

References are not available for this document.

Citations

Citations are not available for this document.